Novo Nordisk slashes Ozempic costs for cash buyers, sparking a 39% surge in GoodRx and shaking up the weight-loss wars.

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.